
Related topics: Drug Delivery
Gerresheimer reports its second quarter profit from operations has grown year-on-year from €11.8m ($15.1m) to €24.8m.
Improvement of the financial results was underpinned by “further solid growth of the pharma business”, said Gerresheimer. This helped Gerresheimer grow revenues year-on-year by 6.8 per cent, excluding the sold technical plastic systems business. Revenues totalled €268.8m.
"We want to remain on our profitable growth path. To this end we will push ahead with the globalisation of our business”, said Uwe Rohrhoff, CEO of Gerresheimer.
In response to the positive second quarter results Gerresheimer has slightly raised the lower limit of its 2010 revenue guidance.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions
© 2012 - William Reed Business Media SAS - All rights reserved. ![]()